We are a precision diagnostics company that quantifies biology to create powerful molecular diagnostics. We work to improve disease detection by counting molecules with our proprietary molecular counting platform. We place patients at the forefront of everything we do. We are currently applying our proprietary technology to non-invasive prenatal screening and liquid biopsy.
Channel Medsystems™ mission is to empower every woman to take control of her health journey and live her best life. Channel develops easy-to-use, safe, and cost-effective medical devices, resulting in exceptional outcomes and superior patient comfort that are accessible to all women. It's technology, Cerene® Cryotherapy, is a well-tolerated in-office endometrial ablation that significantly reduces heavy menstrual bleeding, while preserving uterine cavity access for future diagnostic evaluations.
CNY Fertility's mission is to ensure every person has the ability to access the highest quality reproductive services needed to start or expand their family. Most of the treatments at CNY Fertility cost less than 1/3 the national average and financing is available to everyone. CNY Fertility also offers fertility care to everyone regardless of age, BMI, FSH/AMH, or the number of failed cycles. With over 9 locations, CNY Fertility treats patients from across the United States.
.png)
Florida Blue is a leader in Florida's health care industry. Our mission is to help people and communities achieve better health. Headquartered in Jacksonville, Fla., it is an independent licensee of the Blue Cross and Blue Shield Association, an association of independent Blue Cross and Blue Shield companies.
A global leader in women’s health, Hologic enables people to lead healthier lives everywhere, every day. The Diagnostic Solutions division delivers on this commitment by developing and providing innovative cytology, molecular and perinatal testing. With instrumentation and assays rooted in science, Hologic helps guide patient care and enable earlier detection.
Medical Malpractice Defense and Asset Protection for doctors
Mayne Pharma is focused on applying its track record of innovation and success to commercialize branded and generic pharmaceuticals, offering patients better and more accessible medicines. The company has an extensive Women's Health portfolio focused on contraceptives, including its flagship, newly FDA-approved, novel birth control pill. https://reference.medscape.com/drug/nextstellis-estetrol-drospirenone-4000126
We aspire to redefine care for women and for men through purpose-driven science, empowering medicines, and transformative advocacy. Our purpose is resolute and fueled by the opportunity to improve the lives of millions of women and men, many impacted by diseases during their most productive years of life.
Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives.
Pacira BioSciences, Inc. (Nasdaq: PCRX) is committed to providing a non-opioid option to as many patients as possible to redefine the role of opioids as rescue therapy only. Pacira has three commercial-stage non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting, local analgesia approved for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular, injection
